COVID-19 Disrupts Important Research Projects, Shutters Labs Indefinitely

Survey reveals wide-ranging adverse impact of COVID-19 on research
American Physiological Society (APS)

Newswise — Rockville, Md. (August 6, 2020)—As COVID-19 —the disease caused by the novel coronavirus— has sickened millions and killed more than 155,000 people in the U.S., the virus has also halted critical physiological research and shuttered labs across the nation. This according to nearly 100 researchers who responded to an informal poll conducted by the American Physiological Society (APS). Survey respondents reported furloughs, layoffs and delays in research completion. The immediate fallout is vast, and the effects could be long-lasting. 

Fifty-eight percent of trainee respondents said lab closures due to COVID-19 may increase the time it takes them to complete their training. Forty-five percent of respondents reported setbacks in long-term, time-sensitive experiments or loss of specialized research resources.

“Due to the immediate shutdown of the lab, we were forced to abandon time-sensitive animal experiments in which we had already invested a number of months in data acquisition and interventions,” said one researcher. “We will need to restart these experiments, but are unsure of how this work will be funded.”

Among other findings:

  • 28% of faculty-level researchers have experienced furloughs or salary reductions.
  • 60% of researchers have experienced delays in recruiting new students, staff and postdoctoral researchers due to closures and hiring freezes.
  • 82% of faculty-level researchers believe that coronavirus-related closures will negatively impact their ability to apply for grants and maintain continuous funding.

The survey was led by Rebecca Osthus, PhD, associate director of government relations and science policy at APS. Osthus said the survey was conducted “so that we could hear directly from our members about how COVID-19 has disrupted biomedical research. We wanted to know what challenges they are facing and what they need to recover and get their research back on track. We plan to share this information with Congress as we advocate for additional funding and with federal agencies that are trying to respond to the needs of the research community.”

Learn more about the survey at www.physiology.org/covid19survey. Find more coverage on how COVID-19 is affecting the biomedical research community, including the ripple effects of nationwide lab closures, in the July issue of The Physiologist Magazine.

NOTE TO JOURNALISTS: To schedule an interview, please contact the APS Communications Office or call 301.634.7314. Find more research highlights in our News Room.

Physiology is a broad area of scientific inquiry that focuses on how molecules, cells, tissues and organs function in health and disease. The American Physiological Society connects a global, multidisciplinary community of more than 10,000 biomedical scientists and educators as part of its mission to advance scientific discovery, understand life and improve health. The Society drives collaboration and spotlights scientific discoveries through its 16 scholarly journals and programming that support researchers and educators in their work.

 




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.06226